全文获取类型
收费全文 | 58898篇 |
免费 | 5269篇 |
国内免费 | 2684篇 |
专业分类
耳鼻咽喉 | 561篇 |
儿科学 | 862篇 |
妇产科学 | 851篇 |
基础医学 | 8175篇 |
口腔科学 | 1368篇 |
临床医学 | 6394篇 |
内科学 | 10246篇 |
皮肤病学 | 802篇 |
神经病学 | 4468篇 |
特种医学 | 2240篇 |
外国民族医学 | 26篇 |
外科学 | 7130篇 |
综合类 | 6344篇 |
现状与发展 | 5篇 |
一般理论 | 24篇 |
预防医学 | 3754篇 |
眼科学 | 1351篇 |
药学 | 5707篇 |
12篇 | |
中国医学 | 1670篇 |
肿瘤学 | 4861篇 |
出版年
2023年 | 433篇 |
2022年 | 1155篇 |
2021年 | 1684篇 |
2020年 | 1178篇 |
2019年 | 1230篇 |
2018年 | 1618篇 |
2017年 | 1359篇 |
2016年 | 1375篇 |
2015年 | 1881篇 |
2014年 | 2244篇 |
2013年 | 2320篇 |
2012年 | 3505篇 |
2011年 | 3563篇 |
2010年 | 2270篇 |
2009年 | 1869篇 |
2008年 | 2802篇 |
2007年 | 2970篇 |
2006年 | 2847篇 |
2005年 | 2541篇 |
2004年 | 2129篇 |
2003年 | 2073篇 |
2002年 | 1777篇 |
2001年 | 2847篇 |
2000年 | 2693篇 |
1999年 | 2304篇 |
1998年 | 977篇 |
1997年 | 783篇 |
1996年 | 593篇 |
1995年 | 540篇 |
1994年 | 464篇 |
1993年 | 381篇 |
1992年 | 1189篇 |
1991年 | 1046篇 |
1990年 | 936篇 |
1989年 | 967篇 |
1988年 | 881篇 |
1987年 | 807篇 |
1986年 | 749篇 |
1985年 | 664篇 |
1984年 | 437篇 |
1983年 | 338篇 |
1982年 | 203篇 |
1981年 | 160篇 |
1980年 | 132篇 |
1979年 | 214篇 |
1978年 | 94篇 |
1974年 | 92篇 |
1973年 | 101篇 |
1972年 | 94篇 |
1971年 | 98篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
141.
Lou Zhong-jin罗仲金 Wang Ling王玲 Liu Qing 刘庆Tian Guang-zhao田光兆 Hu Xiao-su胡孝素 Huang Guang-qi黄光琦Qian Fang钱方 Ran Rui-tu冉瑞图West China University of Medical Sciences ChengduHuang De-huai黄德淮Chengdu Fifth People''s Hospital Chengdu 《中华医学杂志(英文版)》1987,100(9):740-744
Comparative studies are made on the relative
percentages of amino acid content and LDH isozyme
by electrophoresis and Slab-PAGE in adult worms
of Ascaris lumbricoides, Ascaris suum and Toxocara
canis. The results show that there are remarkable
differences of Arg and His of 17 amino acids bet.
ween Toxocara canis and human intestinal ascaris,
human biliary ascaris and pig ascaris; there are also
obvious differences of band positions of LDH
isozyme electrophoretic patterns and band position
and amount of slab-PAGE patterns among them,
whereas no marked differences are found in these
three indices in human intestinal ascaris, human
biliary ascaris and pig ascaris. 相似文献
142.
143.
144.
应用生理性成骨力值概念治疗骨折与骨不连——兼论MO现象与有效固定 总被引:2,自引:2,他引:0
张春才 禹宝庆 许硕贵 苏佳灿 王家林 牛云飞 康庆林 付青格 任可 张鹏 高堂成 张雪松 严望军 王冠军 汪光晔 万岷 李波 孙建伟 王仁 丛永健 杨郁野 郑医红 李格当 刘欣伟 管华鹏 《中国骨伤》2007,20(6):361-363
治疗骨折与术后合并的骨不连,至今仍是骨创伤领域的难题之一。研究分析当前的学术思想,探索更接近骨愈合规律的理念与技术,是必然的学术趋势。1当前骨创伤理论与技术1.1AO从20世纪50年代起,AO组织提出解剖复位与骨块间坚强固定与加压的概念。50年间,由于伴随生物材料学的发展和内固定形式的进步,业已成为治疗骨折与骨不连的主要理论与方法,并取得了瞩目的成就,但同时也发现了存在并需继续探讨的若干问题。(1)偏心类的固定模式,如加压钢板,其疗效超越一般非加压性钢板。但同时也发现:①内固定期间,骨质萎缩,骨痂纹理凌乱或难觅骨痂;②钢板… 相似文献
145.
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. 总被引:3,自引:0,他引:3
Pavel Sova Xiao-Wei Ren Shaoheng Ni Kathrin M Bernt Jie Mi Nancy Kiviat André Lieber 《Molecular therapy》2004,9(4):496-509
We have constructed a new capsid-modified adenovirus (Ad) vector that specifically replicates in tumor cells and expresses TNF-related apoptosis-inducing ligand (TRAIL). The Ad capsid contains short-shafted fibers derived from Ad serotype 35, which allow for efficient infection of malignant tumor cells, and largely avoids innate toxicity after intravenous application. Replication-dependent homologous recombination in Ad genomes was used to achieve tumor-specific expression of Ad E1a (to mediate viral replication) and TRAIL (to mediate apoptosis and enhance release of progeny virus from infected cells). We demonstrated that our oncolytic vector (Ad5/35.IR-E1A/TRAIL) induced apoptosis in human tumor cell lines derived from colorectal, lung, prostate, and liver cancer. Both in vitro and in vivo tumor models showed efficient intratumoral spread of this vector. In a model for metastatic colon cancer, tail vein infusion of Ad5/35.IR-E1A/TRAIL resulted in elimination of preestablished liver metastases. Intravenous injection of this vector caused a transient elevation of serum glutamic pyruvic transaminase in tumor-bearing mice, which we attributed to factors released from apoptotic tumor cells. Liver histology analyzed at day 14 after virus injection did not show signs of hepatocellular damage. This new oncolytic vector represents a potentially efficient means for gene therapy of metastatic cancer. 相似文献
146.
147.
148.
Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate. 总被引:1,自引:0,他引:1
Romain Dayer Isabelle Badoud René Rizzoli Patrick Ammann 《Journal of bone and mineral research》2007,22(10):1526-1533
Protein deficiency is associated with impaired titanium osseointegration. We studied whether systemic treatment with PTH or pamidronate could influence the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake. PTH or pamidronate prevented the deleterious effects of protein undernutrition on bone microarchitecture close to the implant and on mechanical fixation. PTH even significantly improved implant osseointegration. INTRODUCTION: Protein deficiency is highly prevalent among elderly patients hospitalized in orthopedic wards. Reduced protein intake impairs titanium osseointegration in rats. Whether stimulator of bone formation or inhibitor of bone resorption could improve implant osseointegration under protein deprivation is not known. We studied the effects of systemic treatment with PTH or pamidronate on the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake. MATERIALS AND METHODS: We measured the resistance to pull-out 1-mm-diameter titanium rods implanted into the proximal tibias of 49 adult female rats receiving a normal or an isocaloric low protein diet. After 2 wk on either diet, the implants were inserted, and the rats received PTH(1-34), pamidronate or saline vehicle for 8 wk. The tibias were removed for microCT morphometry, followed by the evaluation of pull-out strength. RESULTS: Pull-out strength was lower in rats fed an isocaloric low protein diet compared with rats fed a normal protein intake (-29%). PTH and pamidronate significantly increased pull-out strength in animals fed a normal or a low protein diet, the effect of PTH being of higher magnitude. The PTH- or pamidronate-mediated increase in pull-out strength was associated with significant increases of relative bone volume, bone-to-implant contact, and trabecular thickness, whereas trabecular spacing was reduced, in the vicinity of the implants. CONCLUSIONS: We confirmed that isocaloric low protein intake impairs titanium implant osseointegration. PTH or pamidronate prevented the deleterious effects of protein undernutrition and even significantly improved the implant osseointegration. These results indicate that systemic administration of PTH or pamidronate could be considered for preventing uncemented arthroplasty loosening in protein undernourished patients. 相似文献
149.
150.
Jacobo E Mintzer Larry E Tune Christopher D Breder René Swanink Ronald N Marcus Robert D McQuade Andy Forbes 《The American journal of geriatric psychiatry》2007,15(11):918-931
OBJECTIVE: To assess the efficacy and safety of aripiprazole for psychosis associated with Alzheimer dementia (AD). METHODS: In this double-blind, multicenter study, 487 institutionalized patients with psychosis associated with AD were randomized to placebo or aripiprazole, 2, 5 or 10 mg/day. Primary efficacy assessment was the mean change from baseline to week 10 on the Neuropsychiatric Inventory-Nursing Home (NPI-NH) version Psychosis Subscale score. Secondary measures included NPI-NH Total, Clinical Global Impression-Severity of Illness (CGI-S), Brief Psychiatric Rating Scale (BPRS) Core and Total, and the Cohen-Mansfield Agitation Inventory (CMAI) scores. RESULTS: Aripiprazole 10 mg/day showed significantly greater improvements (mean change [2 x SD]) than placebo on the NPI-NH Psychosis Subscale (-6.87 [8.6] versus -5.13 [10.0]; F = 6.29, df = 1, 422, p = 0.013 by analysis of covariance [ANCOVA]); CGI-S (-0.72 [1.8] versus -0.46 [1.6]; F = 4.68, df = 1, 419, p = 0.031 [ANCOVA]); BPRS Total (-7.12 [18.4] versus -4.17 [21.6]; F = 4.72, df = 1, 399, p = 0.030 [ANCOVA]); BPRS Core (-3.07 [6.9] versus -1.74 [7.8]; F = 7.30, df = 1, 407, p = 0.007 [ANCOVA]); CMAI (-10.96 [22.6] versus -6.64 [28.6]; F = 5.23, df = 1, 410, p = 0.023 [ANCOVA]), and NPI-NH Psychosis response rate (65 versus 50%; chi(2) = 5.52, df = 1, p = 0.019 [CMH]). Aripiprazole 5 mg/day showed significant improvements versus placebo on BPRS and CMAI scores. Aripiprazole 2 mg/day was not efficacious. Cerebrovascular adverse events were reported: aripiprazole 2 mg/day, N = 1; 5 mg/day, N = 2; 10 mg/day, N = 4; placebo, N = 0. No deaths in any group (aripiprazole 2 mg/day, 3%; 5 mg/day, 2%; 10 mg/day, 7%; placebo, 3%) were considered to be treatment-related. CONCLUSION: Aripiprazole 10 mg/day was efficacious and safe for psychosis associated with AD, significantly improving psychotic symptoms, agitation, and clinical global impression. However, clinicians should be aware of the safety considerations of atypical antipsychotic uses in this population. 相似文献